May 15, 2014
SITC Announces "NSCLC Immunotherapy: A New Hope"
The first educational video of its kind!
Society for Immunotherapy of Cancer (SITC) is excited to announce the launch of “Non-Small Cell Lung Cancer Immunotherapy: A New Hope,” the first educational video of its kind, offering new hope for patients with non-small cell lung cancer (NSCLC).
This video follows a patient’s journey from her diagnosis of NSCLC through the process of learning about cancer immunology, leading to her consideration of cancer immunotherapy treatments via clinical trial participation. Through an engaging white board animated format, this video provides patients with easy to understand and unbiased information on how cancer immunotherapy works as well as informative discussion regarding cancer immunotherapy clinical trials for patients with NSCLC.
Watch and Share
We encourage you to watch this video and help SITC and our partnering organizations spread awareness about the excitement and the hope that cancer immunotherapy clinical trials can offer to patients with NSCLC today. Please forward this email to your patients, colleagues and staff and also share it with family and friends on your social media accounts!
By sharing this video we can increase patient knowledge and awareness of cancer immunology and immunotherapy and promote the advancement of cancer immunotherapy as a fourth standard of care. Let’s strive to make the word “cure” a reality for patients everywhere!
Video Background
The leadership of SITC responded to the growing demand for patient-centered educational resources by setting an agenda to expand upon the Society’s patient-level impact in the field of immuno-oncology, resulting in the creation of this video.
SITC facilitated the creation of this video by merging content provided by lung cancer immunotherapy experts with input from focus group volunteers. SITC collaborated with other leading organizations across the continuum of cancer care (Association of Community Cancer Centers, Bonnie J Addario Lung Cancer Foundation, Cancer Support Community, Lung Cancer Alliance, and LUNGevity) who provided volunteers to shape the video content. These groups are also promoting and distributing the video to their members to ensure a wide range of viewers to spread the message of hope.
Because SITC consulted a range of stakeholders including clinical oncologists, nurses, patients, social workers and patient advocates, this production offers a balanced view of NSCLC immunotherapy options aimed at patient understanding.
Thank you for helping SITC spread awareness about the new hope that cancer immunotherapy clinical trials can offer patients with NSCLC through sharing this video!
